Melanoma Research
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Melanoma Research (print: ISSN 0960-8931, online: ISSN 1473-5636) is a peer-reviewed medical journal published by Lippincott Williams & Wilkins since 1991. The journal publishes current findings on melanoma. Articles include both experimental and clinical research in a broad range of related subjects, including genetics, molecular biology, biochemistry, cell biology, photobiology, pathology, and immunology, and advances in clinical oncology influencing the prevention, diagnosis, and treatment of melanoma. Melanoma Research is published bimonthly. The current editor-in-chief is F.J. Lejeune. Less
Key Metrics
Journal Specifications
- PublisherLIPPINCOTT WILLIAMS & WILKINS
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year1991
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Melanoma Research been publishing? 
The Melanoma Research has been publishing since 1991 till date.
How frequently is the Melanoma Research published?
Melanoma Research is published Bi-monthly.
Who is the publisher of Melanoma Research?
The publisher of Melanoma Research is LIPPINCOTT WILLIAMS & WILKINS.
Where can I find a journal's aims and scope of Melanoma Research?
For the Melanoma Research's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Melanoma Research on editage?
For the Melanoma Research metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Melanoma Research?
The eISSN number is 1473-5636 and pISSN number is 0960-8931 for Melanoma Research.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Immunotherapy, Lymph node, Melanoma, Copy number gain, Progression-free survival, Vemurafenib, MEK inhibitor, Overall survival, Dabrafenib, Clinicopathological features, Cutaneous melanoma, Confidence interval, Surgical resection, Hemophagocytic lymphohistiocytosis, Advanced melanoma, Sentinel lymph node, Toxicity, Polymyositis, Cell cycle, Complete response.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.